We are thrilled to announce the exciting collaboration between Knight Diagnostic Laboratories and the Knight Cancer Research Institute, focusing on the groundbreaking elio plasma focus Liquid Biopsy Panel for solid tumors. KDL will be the first institute in the Pacific Northwest to launch this FDA approved innovative technology, and we are eager to bring our product experts to meet with your team and discuss the potential impact this collaboration will have on cancer research and patient treatment.
We look forward to connecting with you soon and exploring how this partnership can pave the way for new advancements in oncology!
Agenda:
11:00 am - Seminar Presentation in the KCRB Auditorium featuring
- Joanna Pucilowska,MS, PhD KDL, Director of Cancer Omics Services Scientific Partnerships & Business Development
- Kenneth Valkenburg, PhD Director of Research & Development (PGDx)
- Jennifer Jacksin, PhD Director of Translational Strategy, R&D (PGDx)
12:00pm - Lunch to be provided and time to connect with your KDL & PGDx team members & leaders.
